Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	0.00	0.00	0.00
Graham Fair Price	0.00	0.25	0.25
PEG	inf	0.00	0.49
Price/Book	-5.44	0.91	0.96
Price/Cash Flow	5.44	-360.54	-381.27
Prices/Earnings	5.44	-23.33	-24.67
Price/Sales	5.44	-264.51	-279.72
Price/FCF	5.44	-360.54	-381.27
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	0.00	2.83	2.83
ROA	0.00	< 0.005	< 0.005
ROE	< 0.005	< 0.005	0.00
ROIC	< 0.005	< 0.005	0.00
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.00	0.00	0.00
Dividends QOQ	0.20	0.00	inf
EBIT QOQ	0.49	0.00	inf
EPS QOQ	0.50	0.00	inf
FCF QOQ	0.57	0.00	inf
Revenue QOQ	0.73	0.00	inf
Naive Interpretation	member

03 - Financial Growth · Not Interpreted

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	-97.22	-97.22	0.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.00	0.00	0.00
Quick Ratio	49.52	49.52	0.00
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	0.53	0.53	0.00
Cash	0.17	0.17	0.00
Capex	0.00	0.00	0.00
Free Cash Flow	< 0.005	< 0.005	0.00
Revenue	< 0.005	< 0.005	0.00
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	49.52	49.52	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.00	0.00	0.00
Naive Interpretation	Member

06 - Financial Health · Bad

Rating